Task Forces

Task Forces and Affiliated Networks

Fertility Preservation

Mission Statement

The Task Force promotes knowledge among health care workers and the public on infertility induced by treatment of gynaecologic cancers through national and international collaboration among Oncologists, Reproductive Specialists, and Allied Health Workers to promote research, education and to develop new strategies of fertility preservation.


The Task Force’s initial objectives will focus on fertility preservation in all gynaecologic cancers in which fertility preservation techniques should be offered to patients. As a cooperating counterpart to the frequently used techniques of reproductive medicine (e.g. cryopreservation of ovarian tissue and oocytes), this task force will mainly focus on the feasibility and safety of fertility preservation techniques, including conservative medical management of endometrial cancer and surgical procedures maintaining fertility (e.g. trachelectomy in cervical cancer).


The main activities within the next two years are establishing networks and cooperation with regional and supra-regional groups in order to increase public awareness and optimise fertility preservation techniques.  It will do so by evaluating current available evidence and consecutively establishing evidence-based guidelines. A special session on Fertility Preservation is held during the ESGO Biennial Meetings.

Working Group

Dominik Denschlag, Freiburg, Germany

Vesna Kesic, Serbia
Nicholas Reed, UK
Alexandros Rodolakis, Greece
Mandy Mangler, Germany
Philippe Morice, France

All ESGO members with a special interest in fertility preservation are cordially invited to register by clicking here.

Task Force working group contact:


Prevention & Diagnostics Task Force


The task force aims to improve the quality of care in prevention of gynecological cancer, provide education in the field of prevention through collaboration with other European societies in the field prevention gynecological cancer, and increasing awareness about prevention among general public, medical professionals and decision making politicians.


1. Quality of care

Joint work with the ESGO Guidelines committee on the Recommendations for Screening of Cervical cancer (Implementation of screening and vaccination, Management of positive screening test and Quality Assurance indicators)

2. Education

  • Involvement in organization of the State of Art Conference: Prevention in Gynaecological Malignancies in Antalya, 8-10 September, 2016

  • Development of Picture gallery which will include not only colposcopy but also cytology and pathology pictures, case reports and clinical problems.

  • Development of training courses about prevention and/or colposcopy for tarinees in gynecological onclogy

  • Propose implementing prevention and/or colposcopy training in the curriculum for gynecological oncology

3. Collaboration

  • Future development of collaboration with European Society for Pathology (joint work on educational contents)

  • Initiating collaboration with European Society for Colposcopy (planning joint colposcopy courses involving ENYGO, supporting implementation of already defined and obtained European-wide consensus on training structure and standards)

  • Initiating and supporting ccollaboration with MASCC in the field of tertiary prevention (palliative care)

4. Awareness

  • Improving collaboration with ENGAGe in scientific support for the work with patients (i.e. lectures, preparing the text for brochures)

  • Participation in promotional activities in order to raise public awareness about prevention (promotion of Prevention broche)

Working Group


Vesna Kesic, Belgrade, Serbia


Murat Glutekin, Turkey

Dina Kudriani, Georgia

Ermina Ilijazovic, Bosnia and Herzegovina

Mihail Katsuba, Russia

Jiri Slama, Czech Republic
Task Force Working Group contact:



Mission Statement

The Task Force addresses the psychological responses of patients and their families to gynaecological cancer at all stages and the factors that may influence coping with the disease.

Information about specific psychological interventions regarding prevention, diagnosis, treatment and rehabilitation will be provided.


The Task Force’s primary objective is to distribute knowledge about the interrelations between physical, psychological, social, and behavioural aspects of gynecological cancer and the psycho-social therapeutic options to support patients, families and their care-givers.

The Task Force will also build collaborations across countries and disciplines to develop research projects and research-inspired practice.


In 2010, collaboration between ESGO and IPOS (International Society of Gynaecological Oncology) started with a knowledge exchange and implementation of an IPOS workshop at ESGO 17 International meeting in Milan 2011, and an ESGO workshop at the IPOS 13 World Congress in Antalya 2011.

In 2012, the collaboration culminated by signing the ESGO & IPOS Partnership aiming to provide ESGO members with an educational Core Curriculum on Psycho-Oncology available on eAcademy and has been implemented into the official ESGO & EBCOG subspecialist training programme in Gynaecological Oncology.

The psychosocial training workshop “Anxiety, Depression and Distress Management”  focused on a set of core psycho-oncological topics and skills was organised during the ESGO 17th International Meeting in Milan, in collaboration with IPOS (International Psycho-Oncological Society). This workshop is available online as a part of the ESGO17 webcast.


Working Group

Annette Hasenburg (Germany)

Vesna Kesic (Serbia)
Frederic Amant (Belgium)
Patriciu Achimas-Cadariu (Romania)
Leen Aerts (Belgium)
Astrid Pascal (Belgium)

Task Force Working Group contact:


ESGO 2019 Athens Congress

November 2-5, 2019



Read More

3rd ESGO Advanced Course in Ovarian Cancer Surgery

December 5 - 7, 2019
Hamburg, Germany




Advanced Course on Multidisciplinary Management of Cervical Cancer

January 15-17, 2020
Institut Gustave Roussy, Paris, France

Read More


Advanced Course in Fertility Sparing Management of Gynaecological Cancers

February 27-29, 2020
Hamburg, Germany